Kevin Grogan The US and Drug Administration has revoked approval of Roche's Avastin as a treatment for breast cancer, bringing to an end a long battle between drugmaker and regulator.   In July, the agency’s Oncologic Drugs Advisory Committee (ODAC) voted 12-1 in July 2010 to remove the brea

By Angela Epstein There is growing disquiet in the medical community. The NHS breast-cancer screening programme, which invites all women to have three-yearly X-rays (mammograms) from the age of 50, has been said by some doctors to ‘do more harm than good’. This, coupled with the fact that one wom

"I know I need this medicine to help lower my chance of cancer recurrence, but it makes my joints ache and stiff. It makes me feel old and I am not sure I can take this medication much longer." It's a story that oncologists across the country hear frequently from patients taking aromatase inhibitor

By Steve Johnson sjohnson@mercurynews.com. To the despair of some critically ill patients, a federal agency on Friday revoked its approval of Avastin for treating breast cancer after determining the widely used drug developed by South San Francisco-based Genentech fails to help patients live longe

Women who survive primary breast cancer may have significant neurological impairment, especially if they have been treated with chemotherapy, shows research published in this month’s Archives of Neurology. Older and less educated women were especially vulnerable to altered brain function. Researche

Stichting Pink Ribbon, a Dutch charity foundation, has only spent $390 thousand of its $27 million donation revenues on breast cancer research, as revealed by a thorough investigation conducted by the Dutch television (NOS). In 2009 and 2010 no funds were used for breast cancer research. In compari

(CBS News)  Cancer kills about 570,000 Americans each year, but there's hope that an experimental treatment could bring those numbers down. The idea is to train the body's own immune system to fight the disease, and if it works, it might be a way to prevent cancer from occurring at all.

Computerworld - The method for diagnosing breast cancer has gone mostly unchanged since the 1920s: doctors examine a small set of cancer cells to determine the disease's aggressiveness and the patient's prognosis. This week, however, computer scientists and pathologists at Stanford University desc

  Drinking raises risk of benign breast disease, a cancer risk factor Among teen girls with a family history of breast cancer, there is a significant association between the amount of alcohol consumed and the risk of getting benign breast disease, which is a known breast cancer risk factor.

Breast cancer microscopic images can be evaluated by a computer trained to analyze them, according to Stanford researchers.   “The computer strips away that bias and looks at thousands of factors to determine which matter most in predicting survival,” senior study author Dr. Daphne Koller, a